{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:36:36Z","timestamp":1761100596541},"reference-count":108,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2002,9,1]],"date-time":"2002-09-01T00:00:00Z","timestamp":1030838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Haematology"],"published-print":{"date-parts":[[2002,9]]},"DOI":"10.1053\/beha.2002.0223","type":"journal-article","created":{"date-parts":[[2002,12,11]],"date-time":"2002-12-11T01:48:30Z","timestamp":1039571310000},"page":"481-504","source":"Crossref","is-referenced-by-count":5,"title":["Allogeneic haemopoietic stem cell transplantation for non-Hodgkin's lymphoma"],"prefix":"10.1053","volume":"15","author":[{"given":"Cynthia L.","family":"Toze","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Barnett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/beha.2002.0223_RF1","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0002-9343(80)90472-6","article-title":"Dose: a critical factor in cancer chemotherapy","volume":"69","author":"Frei","year":"1980","journal-title":"American Journal of Medicine"},{"key":"10.1053\/beha.2002.0223_RF2","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1182\/blood.V77.3.649.649","article-title":"Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation","volume":"77","author":"Jones","year":"1991","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0223_RF3","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/00007890-198102000-00014","article-title":"Identical twin marrow transplantation for patients with leukemia and lymphoma","volume":"31","author":"Goldman","year":"1981","journal-title":"Transplantation"},{"key":"10.1053\/beha.2002.0223_RF4","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1182\/blood.V58.3.509.509","article-title":"Treatment of non-Hodgkin's lymphoma with marrow transplantation in identical twins","volume":"58","author":"Appelbaum","year":"1981","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0223_RF5","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/hon.2900010205","article-title":"Treatment of non-Hodgkin's lymphoma with chemoradiotherapy and allogeneic marrow transplantation","volume":"1","author":"Appelbaum","year":"1983","journal-title":"Hematological Oncology"},{"key":"10.1053\/beha.2002.0223_RF6","first-page":"641","article-title":"Immune system reconstitution following allogeneic bone marrow transplantation in man: a multiparameter analysis","volume":"8","author":"Elfenbein","year":"1976","journal-title":"Transplantation Proceedings"},{"key":"10.1053\/beha.2002.0223_RF7","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1200\/JCO.1986.4.4.480","article-title":"High-dose chemotherapy, fractionated total-body irradiation, and allogeneic marrow transplantation for malignant lymphoma","volume":"4","author":"Phillips","year":"1986","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0223_RF8","first-page":"81","volume":"1","author":"Ernst","year":"1986","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2002.0223_RF9","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1200\/JCO.1987.5.9.1340","article-title":"Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation, and marrow transplantation","volume":"5","author":"Appelbaum","year":"1987","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0223_RF10","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1002\/1097-0142(19820515)49:10<2112::AID-CNCR2820491024>3.0.CO;2-2","volume":"49","year":"1982","journal-title":"Cancer"},{"key":"10.1053\/beha.2002.0223_RF11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/BF00319636","article-title":"Allogeneic bone marrow transplantation for high risk non-Hodgkin's lymphoma during first complete remission","volume":"55","author":"Nademanee","year":"1987","journal-title":"Blut"},{"key":"10.1053\/beha.2002.0223_RF12","first-page":"47","article-title":"Allogeneic marrow transplantation in non-Hodgkin's lymphoma","volume":"5","author":"Copelan","year":"1990","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2002.0223_RF13","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1200\/JCO.1991.9.10.1848","article-title":"Allogeneic bone marrow transplantation for relapsed and refractory lymphoma using genotypically HLA-identical and alternative donors","volume":"9","author":"Lundberg","year":"1991","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0223_RF14","first-page":"591","article-title":"Allogeneic bone marrow transplantation for poor-prognosis non-Hodgkin's lymphoma","volume":"12","author":"Shepherd","year":"1993","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2002.0223_RF15","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1200\/JCO.1995.13.3.596","article-title":"High-dose cyclophosphamide, carmustine, and etoposide followed by allogeneic bone marrow transplantation in patients with lymphoid malignancies who had received prior dose-limiting radiation therapy","volume":"13","author":"Demirer","year":"1995","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0223_RF16","first-page":"299","article-title":"Allogeneic bone marrow transplantation for Hodgkin's and non-Hodgkin's lymphoma","volume":"15","author":"Mendoza","year":"1995","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2002.0223_RF17","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0002-9343(97)89488-0","article-title":"Allogeneic bone marrow transplantation for poor-prognosis lymphoma: response, toxicity, and survival depend on disease histology","volume":"100","author":"van Besien","year":"1996","journal-title":"American Journal of Medicine"},{"key":"10.1053\/beha.2002.0223_RF18","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/sj.bmt.1700904","article-title":"Allogeneic bone marrow transplantation for relapsed and refractory Hodgkin's disease and non-Hodgkin's lymphoma","volume":"20","author":"Dann","year":"1997","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2002.0223_RF19","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/sj.bmt.1701271","article-title":"CD6+ T cell-depleted allogeneic bone marrow transplantation for non-Hodgkin's lymphoma","volume":"21","author":"Soiffer","year":"1998","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2002.0223_RF20","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/sj.bmt.1701209","article-title":"T cell-depleted allogeneic bone marrow transplantation for high-risk non-Hodgkin's lymphoma: clinical and molecular follow-up","volume":"21","author":"Juckett","year":"1998","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2002.0223_RF21","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/oxfordjournals.annonc.a010369","article-title":"Carmustine, etoposide, cytarabine and melphalan as a preparative regimen for allogeneic transplantation for high-risk malignant lymphoma","volume":"10","author":"Przepiorka","year":"1999","journal-title":"Annals of Oncology"},{"key":"10.1053\/beha.2002.0223_RF22","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1046\/j.1365-2141.1999.01666.x","article-title":"Allogeneic bone marrow transplantation in aggressive non-Hodgkin's lymphoma (excluding Burkitt and lymphoblastic lymphoma): a series of 73 patients from the SFGM database","volume":"107","author":"Dhedin","year":"1999","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2002.0223_RF23","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1046\/j.1365-2141.2000.01879.x","article-title":"Preliminary experience of allogeneic stem cell transplantation for lymphoproliferative disorders using BEAM\u2013CAMPATH conditioning: an effective regimen with low procedure-related toxicity","volume":"108","author":"Cull","year":"2000","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2002.0223_RF24","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V75.3.555.555","article-title":"Graft-versus-leukemia reactions after bone marrow transplantation","volume":"75","author":"Horowitz","year":"1990","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0223_RF25","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/sj.bmt.1701587","article-title":"Long-term follow-up of allogeneic bone marrow transplantation in patients with poor prognosis non-Hodgkin's lymphoma","volume":"23","author":"Bernard","year":"1999","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2002.0223_RF26","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1365-2141.1989.tb00224.x","article-title":"Bone marrow transplantation for adult poor prognosis lymphoblastic lymphoma in first complete remission","volume":"73","author":"Milpied","year":"1989","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2002.0223_RF27","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1200\/JCO.1992.10.11.1690","article-title":"Autologous versus allogeneic bone marrow transplantation for non-Hodgkin's lymphoma: a case-controlled analysis of the European bone marrow transplant group registry data","volume":"10","author":"Chopra","year":"1992","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0223_RF28","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1182\/blood.V84.4.1050.1050","article-title":"Prospective comparative trial of autologous versus allogeneic bone marrow transplantation in patients with non-Hodgkin's lymphoma","volume":"84","author":"Ratanatharathorn","year":"1994","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0223_RF29","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/sj.bmt.1701556","article-title":"High-dose therapy with autologous or allogeneic transplantation as salvage therapy for small cleaved cell lymphoma of follicular center cell origin","volume":"23","author":"Stein","year":"1999","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2002.0223_RF30","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3109\/10428199909083388","article-title":"Allogeneic versus autologous bone marrow transplantation for refractory and recurrent low-grade non-Hodgkin's lymphoma: updated results of the Utrecht experience","volume":"34","author":"Verdonck","year":"1999","journal-title":"Leukemia and Lymphoma"},{"key":"10.1053\/beha.2002.0223_RF31","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/sj.bmt.1702625","article-title":"Allogeneic or autologous bone marrow transplantation (BMT) for non-Hodgkin's lymphoma (NHL): results of a provincial strategy","volume":"26","author":"Schimmer","year":"2000","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2002.0223_RF32","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1200\/JCO.2001.19.17.3766","article-title":"Impact of high-dose chemotherapy on peripheral T-cell lymphomas","volume":"19","author":"Rodriguez","year":"2001","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0223_RF33","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1136\/bmj.1.6112.533","article-title":"Comparison of combined and single-agent chemotherapy in non-Hodgkin's lymphoma of favourable histological type","volume":"1","author":"Lister","year":"1978","journal-title":"British Medical Journal"},{"key":"10.1053\/beha.2002.0223_RF34","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1182\/blood.V58.5.920.920","article-title":"Nodular mixed lymphoma: results of a randomized trial failing to confirm prolonged disease-free survival with COPP chemotherapy","volume":"58","author":"Glick","year":"1981","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0223_RF35","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1200\/JCO.1993.11.4.644","article-title":"Long-term follow-up of patients with low-grade malignant lymphomas treated with doxorubicin-based chemotherapy or chemoimmunotherapy","volume":"11","author":"Dana","year":"1993","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0223_RF36","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/oxfordjournals.annonc.a059209","article-title":"Purine analogs in the treatment of low-grade lymphomas and chronic lymphocytic leukemias","volume":"6","author":"Pott-Hoeck","year":"1995","journal-title":"Annals of Oncology"},{"key":"10.1053\/beha.2002.0223_RF37","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1200\/JCO.2000.18.5.947","article-title":"Therapy-related myelodysplasia and secondary acute myelogenous leukemia after high-dose therapy with autologous hematopoietic progenitor-cell support for lymphoid malignancies","volume":"18","author":"Micallef","year":"2000","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0223_RF38","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1200\/JCO.1995.13.5.1096","article-title":"Allogeneic bone marrow transplantation for refractory and recurrent low-grade lymphoma: the case for aggressive management","volume":"13","author":"van Besien","year":"1995","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0223_RF39","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1182\/blood.V90.10.4201","article-title":"Allogeneic versus autologous bone marrow transplantation for refractory and recurrent low-grade non-Hodgkin's lymphoma","volume":"90","author":"Verdonck","year":"1997","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0223_RF40","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1046\/j.1365-2141.1998.00539.x","article-title":"Allogeneic bone marrow transplantation with T-cell-depleted marrow grafts for patients with poor-risk relapsed low-grade non-Hodgkin's lymphoma","volume":"100","author":"Mandigers","year":"1998","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2002.0223_RF41","first-page":"1832","article-title":"Allogeneic bone marrow transplantation for low-grade lymphoma","volume":"92","author":"van Besien","year":"1998","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0223_RF42","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/sj.bmt.1702191","article-title":"Allogeneic bone marrow transplantation for low-grade lymphoma and chronic lymphocytic leukemia","volume":"25","author":"Toze","year":"2000","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2002.0223_RF43","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3109\/10428199909050950","article-title":"High-grade transformation of low-grade non-Hodgkin's lymphomas: mechanisms of tumor progression","volume":"34","author":"Matolcsy","year":"1999","journal-title":"Leukemia and Lymphoma"},{"key":"10.1053\/beha.2002.0223_RF44","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1182\/blood.V74.7.2579.2579","article-title":"Autologous bone marrow transplantation in follicular non-Hodgkin's lymphoma before and after histologic transformation","volume":"74","author":"Schouten","year":"1989","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0223_RF45","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1046\/j.1365-2141.2001.02705.x","article-title":"Autotransplants for histologically transformed follicular non-Hodgkin's lymphoma","volume":"113","author":"Chen","year":"2001","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2002.0223_RF46","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1023\/A:1008349427337","article-title":"High-dose therapy with autologous haematopoietic support in patients with transformed follicular lymphoma: a study of 27 patients from a single centre","volume":"9","author":"Foran","year":"1998","journal-title":"Annals of Oncology"},{"key":"10.1053\/beha.2002.0223_RF47","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1046\/j.1365-2141.2000.02295.x","article-title":"Allogeneic haematopoietic transplantation for Richter's syndrome","volume":"110","author":"Rodriguez","year":"2000","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2002.0223_RF48","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3109\/10428199309148200","article-title":"Combination of t(14;18) and a Burkitt's type translocation in B-cell malignancies","volume":"10","author":"Karsan","year":"1993","journal-title":"Leukemia and Lymphoma"},{"key":"10.1053\/beha.2002.0223_RF49","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1200\/JCO.1999.17.5.1558","article-title":"Small noncleaved, non-Burkitt's (Burkitt-like) lymphoma: cytogenetics predict outcome and reflect clinical presentation","volume":"17","author":"Macpherson","year":"1999","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0223_RF50","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1023\/A:1008380527502","article-title":"Allogeneic hematopoietic transplantation for mantle-cell lymphoma: molecular remissions and evidence of graft-versus-malignancy","volume":"10","author":"Khouri","year":"1999","journal-title":"Annals of Oncology"},{"key":"10.1053\/beha.2002.0223_RF51","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/sj.bmt.1703255","article-title":"Stem cell transplantation for mantle cell lymphoma: should it ever be used outside clinical trials?","volume":"28","author":"Sweetenham","year":"2001","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2002.0223_RF52","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1182\/blood.V63.5.1102.1102","article-title":"An effective therapy for both undifferentiated (including Burkitt's) lymphomas and lymphoblastic lymphomas in children and young adults","volume":"63","author":"Magrath","year":"1984","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0223_RF53","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1200\/JCO.1986.4.6.847","article-title":"Combined modality therapy for adults with small noncleaved cell lymphoma (Burkitt's and non-Burkitt's types)","volume":"4","author":"Bernstein","year":"1986","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0223_RF54","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1182\/blood.V85.3.664.bloodjournal853664","article-title":"Small noncleaved cell lymphoma and leukemia in adults. A retrospective study of 65 adults treated with the LMB pediatric protocols","volume":"85","author":"Soussain","year":"1995","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0223_RF55","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1200\/JCO.1996.14.3.925","article-title":"Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen","volume":"14","author":"Magrath","year":"1996","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0223_RF56","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1023\/A:1008214203225","article-title":"Eighty-one percent event-free survival in advanced Burkitt's lymphoma\/leukemia: no differences in outcome between pediatric and adult patients treated with the same intensive pediatric protocol","volume":"8","author":"Todeschini","year":"1997","journal-title":"Annals of Oncology"},{"key":"10.1053\/beha.2002.0223_RF57","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1600-0609.1985.tb00748.x","article-title":"Intermediate and high-dose ARA-C and m-AMSA (or daunorubicin) as remission and consolidation treatment for patients with relapsed acute leukaemia and lymphoblastic non-Hodgkin lymphoma","volume":"34","author":"Willemze","year":"1985","journal-title":"Scandinavian Journal of Haematology"},{"key":"10.1053\/beha.2002.0223_RF58","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1200\/JCO.1986.4.11.1628","article-title":"Treatment of lymphoblastic lymphoma in adults","volume":"4","author":"Coleman","year":"1986","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0223_RF59","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0277-5379(87)90377-4","article-title":"Preliminary results of consolidation therapy with high-dose cytosine arabinoside for patients with bad-risk or relapsed acute leukemia or lymphoblastic non-Hodgkin's lymphoma","volume":"23","author":"Peters","year":"1987","journal-title":"European Journal of Cancer and Clinical Oncology"},{"key":"10.1053\/beha.2002.0223_RF60","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1200\/JCO.1992.10.7.1078","article-title":"Prognosis and treatment of lymphoblastic lymphoma in adults: a report on 80 patients","volume":"10","author":"Morel","year":"1992","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0223_RF61","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3109\/10428199609054867","article-title":"Adult lymphoblastic lymphoma: clinical features and prognostic factors in 53 patients","volume":"23","author":"Zinzani","year":"1996","journal-title":"Leukemia and Lymphoma"},{"key":"10.1053\/beha.2002.0223_RF62","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/1097-0142(197803)41:3<1059::AID-CNCR2820410339>3.0.CO;2-N","article-title":"Prolonged complete remission following high dose chemotherapy of Burkitt's lymphoma in relapse","volume":"41","author":"Appelbaum","year":"1978","journal-title":"Cancer"},{"key":"10.1053\/beha.2002.0223_RF63","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1200\/JCO.1996.14.9.2465","article-title":"Adult Burkitt's and Burkitt-like non-Hodgkin's lymphoma \u2013 outcome for patients treated with high-dose therapy and autologous stem-cell transplantation in first remission or at relapse: results from the European Group for Blood and Marrow Transplantation","volume":"14","author":"Sweetenham","year":"1996","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0223_RF64","first-page":"283","article-title":"Autologous bone marrow transplantation as consolidation therapy for non-Hodgkin's lymphoma patients with poor prognostic features","volume":"8","author":"Baro","year":"1991","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2002.0223_RF65","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1200\/JCO.1992.10.4.644","article-title":"Autologous bone marrow transplantation for adult poor-risk lymphoblastic lymphoma in first remission","volume":"10","author":"Verdonck","year":"1992","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0223_RF66","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1200\/JCO.1994.12.7.1358","article-title":"High-dose therapy and autologous bone marrow transplantation for adult patients with lymphoblastic lymphoma: results of the European Group for Bone Marrow Transplantation","volume":"12","author":"Sweetenham","year":"1994","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0223_RF67","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1200\/JCO.2001.19.11.2927","volume":"19","author":"Sweetenham","year":"2001","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0223_RF68","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1200\/JCO.1990.8.5.809","article-title":"Allogeneic bone marrow transplantation in adults with Burkitt's lymphoma or acute lymphoblastic leukemia in first complete remission","volume":"8","author":"Troussard","year":"1990","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0223_RF69","first-page":"324","article-title":"Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignancies","volume":"3","author":"Long","year":"1997","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"10.1053\/beha.2002.0223_RF70","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/sj.bmt.1702730","article-title":"Allogeneic stem cell transplantation in a patient with refractory Burkitt's lymphoma using non-myeloablative conditioning regimen","volume":"26","author":"Ungkanont","year":"2000","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2002.0223_RF71","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1200\/JCO.1999.17.12.3835","article-title":"World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting \u2013 Airlie House, Virginia, November 1997","volume":"17","author":"Harris","year":"1999","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0223_RF72","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/oxfordjournals.bmb.a011580","article-title":"Lymphoblastic leukemia and non-Hodgkin's lymphoma","volume":"52","author":"Lilleyman","year":"1996","journal-title":"British Medical Bulletin"},{"key":"10.1053\/beha.2002.0223_RF73","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1200\/JCO.1985.3.5.627","article-title":"Curability of Burkitt's lymphoma with high-dose cyclophosphamide\u2013high-dose methotrexate therapy and intrathecal chemoprophylaxis","volume":"3","author":"Sullivan","year":"1985","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0223_RF74","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1200\/JCO.1986.4.12.1732","article-title":"Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+ ) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine","volume":"4","author":"Murphy","year":"1986","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0223_RF75","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1365-2141.1992.tb06423.x","article-title":"Treatment of advanced stage T cell lymphoblastic lymphoma: results of the United Kingdom Children's Cancer Study Group (UKCCSG) protocol 8503","volume":"82","author":"Eden","year":"1992","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2002.0223_RF76","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/mpo.2950230603","article-title":"Intensive conditioning regimen for bone marrow transplantation in children with high-risk haematological malignancies","volume":"23","author":"Cole","year":"1994","journal-title":"Medical and Pediatric Oncology"},{"key":"10.1053\/beha.2002.0223_RF77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10428199409049645","article-title":"Peripheral T-cell lymphoma in children and adolescents: role of bone marrow transplantation","volume":"14","author":"Gordon","year":"1994","journal-title":"Leukemia and Lymphoma"},{"key":"10.1053\/beha.2002.0223_RF78","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1182\/blood.V90.8.2921","article-title":"High-dose chemotherapy with autologous bone marrow rescue in children with poor-risk Burkitt's lymphoma: a report from the European Lymphoma Bone Marrow Transplantation Registry","volume":"90","author":"Ladenstein","year":"1997","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0223_RF79","first-page":"353","article-title":"Bone marrow transplantation in 46 pediatric patients with non-Hodgkin's lymphoma","volume":"15","author":"Bureo","year":"1995","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2002.0223_RF80","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0002-9343(83)90997-X","article-title":"Bone marrow transplantation for non-Hodgkin's lymphoma in children and young adults","volume":"74","author":"O'Leary","year":"1983","journal-title":"American Journal of Medicine"},{"key":"10.1053\/beha.2002.0223_RF81","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1200\/JCO.1990.8.4.657","article-title":"Bone marrow transplantation for childhood Ki-1 lymphoma","volume":"8","author":"Chakravarti","year":"1990","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0223_RF82","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1182\/blood.V86.8.3247.3247","article-title":"Unrelated donor marrow transplantation in children","volume":"86","author":"Balduzzi","year":"1995","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0223_RF83","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1182\/blood.V88.3.1089.1089","article-title":"Reconstruction of the immune system after unrelated or partially matched T-cell-depleted bone marrow transplantation in children: immunophenotypic analysis and factors affecting the speed of recovery","volume":"88","author":"Kook","year":"1996","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0223_RF84","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/sj.bmt.1701389","article-title":"Matched unrelated allogeneic bone marrow transplantation for recurrent malignant lymphoma in a patient with X-linked lymphoproliferative disease (XLP)","volume":"22","author":"Hoffmann","year":"1998","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2002.0223_RF85","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/sj.bmt.1702765","article-title":"Allogeneic bone marrow transplantation in children failing prior autologous bone marrow transplantation","volume":"27","author":"Hale","year":"2001","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2002.0223_RF86","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/sj.bmt.1701983","article-title":"Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after HLA-mismatched marrow or blood stem cell transplantation","volume":"24","author":"Przepiorka","year":"1999","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2002.0223_RF87","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/sj.bmt.1701947","article-title":"Continuous infusion cyclosporine and nifedipine to day+100 with short methotrexate and steroids as GVHD prophylaxis in unrelated donor transplants","volume":"24","author":"Liesveld","year":"1999","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2002.0223_RF88","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1200\/JCO.2001.19.4.1152","article-title":"CD6+ donor marrow T-cell depletion as the sole form of graft-versus-host disease prophylaxis in patients undergoing allogeneic bone marrow transplant from unrelated donors","volume":"19","author":"Soiffer","year":"2001","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0223_RF89","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/sj.bmt.1700989","article-title":"Allogeneic bone marrow transplantation in patients who relapse after autologous transplantation","volume":"20","author":"Tsai","year":"2002","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2002.0223_RF90","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1200\/JCO.1997.15.4.1595","article-title":"Role of second transplant in the management of poor-prognosis lymphomas: a report from the European Blood and Bone Marrow Registry","volume":"15","author":"Vandenberghe","year":"1997","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0223_RF91","first-page":"665","article-title":"Successful allogeneic bone marrow transplantation for early relapse after autologous bone marrow transplantation in two cases of aggressive high-grade non-Hodgkin's lymphoma","volume":"18","author":"Moreau","year":"1996","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2002.0223_RF92","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/sj.bmt.1700614","article-title":"Bone marrow transplantation after failure of autologous transplant for non-Hodgkin's lymphoma","volume":"19","author":"de Lima","year":"1997","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2002.0223_RF93","first-page":"119","article-title":"Allogeneic bone marrow transplantation in patients with lymphoma relapsing after autologous marrow transplantation","volume":"4","author":"Schouten","year":"1989","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2002.0223_RF94","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1182\/blood.V98.13.3595","article-title":"Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality","volume":"98","author":"Khouri","year":"2001","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0223_RF95","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/00002371-199811000-00007","article-title":"Allogeneic cell-mediated and cytokine-activated immunotherapy for malignant lymphoma at the stage of minimal residual disease after autologous stem cell transplantation","volume":"21","author":"Or","year":"1998","journal-title":"Journal of Immunotherapy"},{"key":"10.1053\/beha.2002.0223_RF96","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/sj.bmt.1703134","article-title":"Reduced intensity conditioning transplants. Enhanced graft-versus-tumor effect following dose-reduced conditioning and allogeneic transplantation for refractory lymphoid malignancies after high-dose therapy","volume":"28","author":"Mohty","year":"2001","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2002.0223_RF97","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1200\/JCO.2000.18.23.3918","article-title":"Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hematopoietic stem-cell transplantation as treatment of resistant Hodgkin's disease and non-Hodgkin's lymphoma","volume":"18","author":"Carella","year":"2000","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0223_RF98","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1182\/blood.V97.3.631","article-title":"Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation","volume":"97","author":"Giralt","year":"2001","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0223_RF99","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1053\/bbmt.2001.v7.pm11760148","article-title":"Successful allogeneic stem cell transplantation with nonmyeloablative conditioning in patients with relapsed hematologic malignancy following autologous stem cell transplantation","volume":"7","author":"Dey","year":"2001","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"10.1053\/beha.2002.0223_RF100","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1200\/JCO.2001.19.14.3340","article-title":"Allogeneic hematopoietic stem-cell transplantation after nonmyeloablative preparative regimens: impact of pretransplantation and posttransplantation factors on outcome","volume":"19","author":"Michallet","year":"2001","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0223_RF101","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1182\/blood.V85.6.1659.bloodjournal8561659","article-title":"Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts","volume":"85","author":"Korbling","year":"1995","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0223_RF102","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/sj.bmt.1701298","article-title":"Faster neutrophil and platelet engraftment, but no differences in acute GVHD or survival, using peripheral blood stem cells from related and unrelated donors, compared to bone marrow","volume":"22","author":"H\u00e4gglund","year":"1998","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2002.0223_RF103","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1038\/sj.bmt.1702349","article-title":"A comparative study of peripheral blood stem cell vs bone marrow transplantation from unrelated donors (MUD): a single center study","volume":"25","author":"Fauser","year":"2000","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2002.0223_RF104","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1056\/NEJM199708073370602","article-title":"Outcome of cord-blood transplantation from related and unrelated donors","volume":"337","author":"Gluckman","year":"1997","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2002.0223_RF105","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1056\/NEJM200106143442402","article-title":"Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors","volume":"344","author":"Laughlin","year":"2001","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2002.0223_RF106","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/sj.bmt.1700781","article-title":"Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effect","volume":"19","author":"van Besien","year":"1997","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/beha.2002.0223_RF107","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1182\/blood.V87.6.2195.bloodjournal8762195","article-title":"Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow tranplantation","volume":"87","author":"Slavin","year":"1996","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0223_RF108","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1093\/annonc\/5.suppl_1.S43","article-title":"Quantitation of follicular non-Hodgkin's lymphoma cells carrying t(14;18) in a patient before and after allogeneic bone marrow transplantation","volume":"5","author":"Meijerink","year":"1994","journal-title":"Annals of Oncology"}],"container-title":["Best Practice &amp; Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692602902239?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692602902239?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T15:53:37Z","timestamp":1583942017000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692602902239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,9]]},"references-count":108,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,9]]}},"alternative-id":["S1521692602902239"],"URL":"https:\/\/doi.org\/10.1053\/beha.2002.0223","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2002,9]]}}}